|
FY2022
12 months to Dec 31, 2022
|
FY2021
11 months to Dec 31, 2021
|
|
|---|---|---|
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| General and administrative expenses paid by related party under promissory note | ||
| Change in fair value of derivative warrant liabilities | ||
| Gain from expiration of over-allotment option | ||
| Income from investments held in Trust Account | ||
| Offering costs associated with derivative warrant liabilities | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Accounts payable | ||
| Accrued expenses | ||
| Due to related party | ||
| Franchise tax payable | ||
| Income tax payable | ||
| Accrued liabilities | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Cash deposited in Trust Account | ||
| Interest released from Trust Account | ||
| Net cash provided by (used in) investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from issuance of Class B common stock to Sponsor | ||
| Proceeds from note payable to related party | ||
| Repayment of note payable to related party | ||
| Proceeds received from initial public offering, gross | ||
| Proceeds received from private placement | ||
| Offering costs paid | ||
| Net cash provided by (used in) financing activities | ||
| Net increase in cash | ||
| Cash - beginning of the period | ||
| Cash - end of the period | ||
| Supplemental disclosure of noncash investing and financing activities: | ||
| Offering costs included in accrued expenses | ||
| Deferred underwriting commissions in connection with the initial public offering | ||
| Supplemental cash flow information: | ||
| Cash paid for taxes |
Loading...
